Purchase Order 75F40120P00363
Award Date 7/8/20
Potential Completion Date 5/16/25
Potential Value $66K
Federal Agency
Awardee
Ultimate Awardee
Not listed Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Jefferson, AR 72079, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a firm fixed-price purchase order contract awarded by the Food and Drug Administration (FDA) to Illumina, Inc., a leading manufacturer of genetic sequencing and genomic analysis technologies. The contract is for the service and maintenance of one Illumina MiSeq sequencing system, with a ceiling value of $34,972.40 and a performance period ending on September 24, 2024. Illumina, a for-profit organization and manufacturer of goods, has been awarded numerous prime federal contracts and...
- This is a firm fixed-price delivery order contract awarded by the Food and Drug Administration (FDA), a civilian federal agency, to Illumina, Inc., a for-profit manufacturer of genomic sequencing technologies. The contract is for $12,450.00 to provide preventative maintenance services for Illumina's MISEQ sequencing system. The contract has an ultimate completion date of June 30, 2018 and does not utilize any set-aside designations. Illumina, headquartered in San Diego, California, is a...
- This is a firm fixed price delivery order contract awarded by the Food and Drug Administration (FDA) to Illumina, Inc. for preventative maintenance services on MiSeq benchtop sequencing instruments. The $184,226.00 contract has an ultimate completion date of December 5, 2016. Illumina is a for-profit manufacturer and provider of genomic sequencing and analysis solutions. Through prior federal contracts, Illumina has supplied a range of sequencing systems, reagents, and related services to...
- This firm fixed-price purchase order was awarded by the Food and Drug Administration (FDA) to Illumina, Inc., a manufacturer of genetic sequencing instruments and reagents, to provide a diagnostic check and system upgrades for the MiSeq Whole Genome Sequencer at six FDA laboratories. The $84,733.20 contract has a completion date of December 31, 2022 and was sole-sourced to Illumina due to the proprietary nature of the MiSeq technology. Illumina has previously provided sequencing systems,...
- The Department of Health and Human Services Food and Drug Administration awarded a $474,577.44 firm fixed price purchase order for preventive maintenance and repair services for Illumina, Inc.'s MiSeq DNA sequencing systems. The contract was awarded on December 4, 2017 with a completion date of December 5, 2019. Illumina is a manufacturer of a range of genetic and genomic analysis instruments and reagents, and has provided similar products and services to support research and diagnostics at...
- This is a firm fixed-price delivery order awarded by the Food and Drug Administration (FDA), a civilian federal agency, to Illumina, Inc., a for-profit manufacturer of genetic sequencing and genomic analysis technologies. The contract is for $40,567.66 and provides MiSeQ reagents and preventative maintenance services. Illumina has been awarded multiple federal contracts and Indefinite Delivery Vehicles (IDVs) from agencies such as the National Institutes of Health, Centers for Disease Control...
- This is a federal contract award from the Food and Drug Administration (FDA) to Illumina, Inc., a for-profit manufacturer of genetic sequencing instruments and related products. The contract is for $58,464.00 to provide preventive maintenance services for two Illumina MiSeq instruments over a 5-year period from April 2022 to July 2027. The contract is a Firm Fixed Price Purchase Order and does not have a set-aside designation. Illumina holds two significant Indefinite Delivery Vehicles (IDVs)...
- This is a firm fixed-price purchase order awarded by the Food and Drug Administration (FDA) to Illumina, Inc., a manufacturer of sequencing and genomic analysis solutions. The contract, valued at $89,573.00, is for preventative maintenance and repair services for the agency's MiSeq sequencing system. The contract has an ultimate completion date of April 30, 2028 and does not include any set-aside designation. Illumina has previously provided a range of sequencing instruments, reagents, and...
- This is a firm fixed-price delivery order contract awarded by the Food and Drug Administration (FDA) to Illumina, Inc., a for-profit manufacturer of genomic sequencing technologies. The contract is for the preventative maintenance of Illumina's MISEQ BENCHTOP SEQUENCER system. The total ceiling value of the contract is $225,606.45, with a period of performance ending on December 5, 2017. The contract was awarded on November 15, 2016 and did not utilize any set-aside designations. Illumina is a...
- This firm fixed price delivery order was awarded by the Department of Health and Human Services Food and Drug Administration to Illumina, Inc., a manufacturer of genetic sequencing instruments and reagents. The contract is for preventative maintenance on a MiSeq benchtop sequencer, with a potential value of $26,157.45 and a completion date of September 29, 2018. Illumina has a history of providing sequencing systems and related products and services to support genomic research and diagnostics at...